🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Taiwan / NCT05863208
Recruiting Not applicable

Artificial Intelligence-assisted Colonoscopy With or Without Endocuff Vision

NCT05863208 · tracked via the Priya Life Science Taiwan tracker
Phase
Not applicable
Started
2023-05-02
Last updated
2025-06-27

Condition(s) studied

Adenoma Detection Rate

Investigational drug(s) / intervention(s)

Artificial intelligenceEndocuff visionHigh-definition endoscope

Artificial intelligence: ASUS EndoAim AI Endoscopy System (ASUS, Taiwan) is used to help the detection of colon adenoma

Endocuff vision: Endocuff vision (Olympus, UK) is used to help the detection of colon adenoma

High-definition endoscope: High-definition endoscope (EVIS-EXERA 290 video system, Olympus Optical, Aizu, Japan) is used under white light for the detection of colon adenoma

Study summary

Adenoma detection rate (ADR) is considered the single most important quality measure in colonoscopy and a higher ADR can reduce the risk of interval colorectal cancer (CRC). Several kinds of new endoscopes and accessories have been accessed to investigate the abilities of improving the ADR. Artificial intelligence (AI) and Endocuff vision are promising new devices to improve the ADR. However, the effect of combining AI and Endocuff vision on ADR remains unclear. The aim of this prospective randomized study is to compare the ADR of AI plus Endocuff vision, AI alone and standard colonoscopy examination.

Eligibility

Sex
ALL
Min age
40 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: Patients over 20 years old are undergoing outpatient sedative colonoscopy in the E-Da Hospital, E-Da cancer Hospital and Chung Shan Medical University Hospital in Taiwan Exclusion Criteria: * A prior history of of inflammatory bowel disease, colorectal cancer, previous bowel resection, Peutz-Jeghers syndrome, familial adenomatous polyposis or other polyposis syndromes * Bleeding tendency * For scheduled endoscopic treatment

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
E-DA Hospital Kaohsiung City Taiwan Recruiting

More E-DA Hospital trials in Taiwan

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05863208 on ClinicalTrials.gov ↗ ← All trials in Taiwan